Efficacy of Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this single-center observational cohort study, based on a registry combining retrospectively and prospectively collected data, is to investigate the short- and long-term effects of irreversible electroporation (IRE) in men and women over the age of 18 who receive IRE for recurrence of pelvic tumors not suitable for other local treatment options such as surgery, thermal ablation, and radiotherapy. The main question it aims to answer is whether IRE is safe in this population, and secondarily, whether it is effective in controlling local tumor recurrence.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Potwierdzona zmiana nowotworowa widoczna na tomografii lub rezonansie magnetycznym wykonanym nie wcześniej niż 6 tygodni przed zabiegiem
- •Nowotwór w miednicy, który nawrócił po wcześniejszym leczeniu
- •Pacjent nie kwalifikuje się do zabiegu chirurgicznego lub radioterapii volgens oceny zespołu specjalistów
✗ Disqualifies
- •Biopsja przeprowadzona bezpośrednio przed zabiegiem wykazała łagodny charakter zmiany
- •Brak wystarczających danych medycznych zarejestrowanych w badaniu
- •Brak wystarczającej obserwacji pacjenta po zabiegu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Amsterdam UMC
Amsterdam, Netherlands
Trial contact
Sonia Triggiani, Radiologist
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/25/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.